Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 10/20 | 1.00 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.67 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.67 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.62 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | QPCT | Q16769 | 1/20 | 0.50 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.50 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.50 |
| ▸ | NAMPT | P43490 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8909610 | 0.80 | CYP19A1 (0.67) | CYP19A1 | |
| SCHEMBL7297515 | 0.80 | CYP11B1 (1.00) | CYP19A1CYP11B1CYP11B2CYP17A1 | |
| SCHEMBL27581650 | 0.80 | CYP19A1 (0.66) | CYP19A1CYP11B1CYP11B2TBXAS1NAMPT | |
| Hydrochloric Acid SCHEMBL10537421 | 0.77 | CYP19A1 (0.62) | CYP19A1CYP11B1CYP11B2CYP17A1POLB | |
| SCHEMBL15754429 | 0.74 | CYP11B1 (1.00) | CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL1171161 | 0.74 | CYP19A1 (0.58) | CYP19A1CYP11B1CYP11B2TBXAS1CYP17A1 | |
| SCHEMBL11006233 | 0.71 | CYP19A1 (0.54) | CYP19A1CYP11B1CYP11B2NAMPT | |
| SCHEMBL8865557 | 0.70 | CYP19A1 (1.00) | CYP19A1CYP11B1CYP11B2TBXAS1CYP17A1 | |
| SCHEMBL563349 | 0.70 | CYP19A1 (0.54) | CYP19A1CYP11B1CYP11B2CYP1A2CYP3A4 | |
| SCHEMBL27705085 | 0.70 | POLB (0.62) | CYP19A1CYP11B1CYP11B2TBXAS1CYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11974977-B2 | Composition and uses for influencing hair growth | LUCOLAS—M.D. LTD (GB) | 2024-05-07 | — | — | US | disclosed |
| US-11324711-B2 | Composition and uses for influencing hair growth | S.W. PATENTVERWERTUNGS LIMITED (GB) | 2022-05-10 | — | — | US | disclosed |
| US-20210290579-A1 | COMPOSITION AND USES FOR INFLUENCING HAIR GROWTH | LUCOLAS M D LTD (GB) | 2021-09-23 | — | — | US | disclosed |
| US-11052059-B2 | Composition and uses for influencing hair growth | LUCOLAS - M.D. LTD (GB) | 2021-07-06 | — | — | US | disclosed |
| EP-2262471-B1 | COMPOSITION AND USES FOR INFLUENCING HAIR GROWTH | LUCOLAS M D LTD (GB) | 2015-10-28 | — | — | EP | disclosed |
| US-20130142890-A1 | COMPOSITION AND USES FOR INFLUENCING HAIR GROWTH | S.W. PATENTVERWERTUNGS LIMITED (GB) | 2013-06-06 | — | — | US | disclosed |
| US-8278291-B1 | Treatment of wrinkles and strias with 4-hydroxyandrostenedione or a derivative thereof | CURADIS GMBH (DE) | 2012-10-02 | — | — | US | disclosed |
| US-20110117218-A1 | composition and uses for influencing hair growth | S.W. Patenverwertwertungs Limited (GB) | 2011-05-19 | — | — | US | disclosed |
| EP-1253966-B1 | SUBSTANCES AND AGENTS FOR POSITIVELY INFLUENCING COLLAGEN | CURADIS GMBH (DE) | 2011-04-27 | — | — | EP | disclosed |
| EP-2262471-A2 | COMPOSITION AND USES FOR INFLUENCING HAIR GROWTH | S.w. Patentverwertungs Limited (GB) | 2010-12-22 | — | — | EP | disclosed |
| WO-2009109402-A2 | COMPOSITION AND USES FOR INFLUENCING HAIR GROWTH | S.W. PATENTVERWERTUNGS LIMITED (GB) | 2009-09-11 | — | — | WO | disclosed |
| US-20070148123-A1 | Substances and agents for positively influencing collagen | WIELAND HEINRICH | 2007-06-28 | — | — | US | disclosed |
| EP-1414467-A2 | TOPICAL TREATMENT FOR MASTALGIA | Schmidt, Alfred (DE) | 2004-05-06 | — | — | EP | disclosed |
| US-20040018991-A1 | Topical treatment for mastalgia | MDI ONCOLOGY, INC. | 2004-01-29 | — | — | US | disclosed |
| EP-1253966-A2 | SUBSTANCES AND AGENTS FOR POSITIVELY INFLUENCING COLLAGEN | Wieland, Heinrich (DE) | 2002-11-06 | — | — | EP | disclosed |
| WO-2002036129-A2 | TOPICAL TREATMENT OF MASTALGIA WITH AROMETESE INHIBITORS SUCH AS ANDROSTENDIONE | SCHMIDT ALFRED (DE) | 2002-05-10 | — | — | WO | disclosed |
| WO-2001012206-A2 | SOY-GLYCINE EXTRACTS AND AROMATASE INHIBITORS FOR POSITIVELY INFLUENCING COLLAGEN | WIELAND HEINRICH (DE) | 2001-02-22 | — | — | WO | disclosed |
| EP-0514198-B1 | 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group | GLAXO GROUP LTD (GB) | 1998-08-05 | — | — | EP | disclosed |
| EP-0514198-A1 | 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group | GLAXO GROUP LIMITED (GB) | 1992-11-19 | — | — | EP | disclosed |
| EP-0505954-A1 | N-Imidazolylmethyl benzofuran derivatives as inhibitors of angiotensin II activity | GLAXO GROUP LIMITED (GB) | 1992-09-30 | — | — | EP | disclosed |